Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Medical Cannabis for the Management of Pain and Quality of Life in Chronic Pain Patients: A Prospective Observational Study
Ramin Safakish, Gordon Ko, Vahid Salimpour, et al.
Pain Medicine (2020) Vol. 21, Iss. 11, pp. 3073-3086
Closed Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
Arun Bhaskar, Alan Bell, Michael Boivin, et al.
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 117
Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies
Suzanne Nielsen, Louisa Picco, Bridin Murnion, et al.
Neuropsychopharmacology (2022) Vol. 47, Iss. 7, pp. 1315-1330
Open Access | Times Cited: 56
Assessment of Medical Cannabis and Health-Related Quality of Life
Thomas R. Arkell, Luke A. Downey, Amie C. Hayley, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2312522-e2312522
Open Access | Times Cited: 36
Cannabis Significantly Reduces the Use of Prescription Opioids and Improves Quality of Life in Authorized Patients: Results of a Large Prospective Study
Philippe Lucas, Susan Boyd, M‐J Milloy, et al.
Pain Medicine (2020) Vol. 22, Iss. 3, pp. 727-739
Open Access | Times Cited: 67
A Systematic Review of Fibromyalgia and Recent Advancements in Treatment: Is Medicinal Cannabis a New Hope?
Hajra Khurshid, Israa A Qureshi, Nasrin Jahan, et al.
Cureus (2021)
Open Access | Times Cited: 50
Long‐term observational studies with cannabis‐based medicines for chronic non‐cancer pain: A systematic review and meta‐analysis of effectiveness and safety
Patric Bialas, Mary‐Ann Fitzcharles, Petra Klose, et al.
European Journal of Pain (2022) Vol. 26, Iss. 6, pp. 1221-1233
Open Access | Times Cited: 33
Comparing the effects of medical cannabis for chronic pain patients with and without co-morbid anxiety: A cohort study
Lara Bapir, Simon Erridge, Martha Nicholas, et al.
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 3, pp. 281-295
Open Access | Times Cited: 18
The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders
Anna Stasiłowicz-Krzemień, Wiktoria Nogalska, Zofia Maszewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5749-5749
Open Access | Times Cited: 6
Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis‐Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry
Michal Kawka, Simon Erridge, Carl Holvey, et al.
The Journal of Clinical Pharmacology (2021) Vol. 61, Iss. 12, pp. 1545-1554
Open Access | Times Cited: 32
UK Medical Cannabis registry: an analysis of clinical outcomes of medicinal cannabis therapy for chronic pain conditions
Michael Harris, Simon Erridge, Mehmet Ergisi, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 15, Iss. 4, pp. 473-485
Open Access | Times Cited: 32
A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two years
Alistair Vickery, Sebastian Roth, Tracie Ernenwein, et al.
PLoS ONE (2022) Vol. 17, Iss. 11, pp. e0272241-e0272241
Open Access | Times Cited: 21
Characteristics of and 3-month health outcomes for people seeking treatment with prescribed cannabis: Real-world evidence from Project Twenty21
Michael T. Lynskey, Anne Katrin Schlag, Alkyoni Athanasiou‐Fragkouli, et al.
Drug Science Policy and Law (2023) Vol. 9
Open Access | Times Cited: 11
Health-related quality of life in patients accessing medicinal cannabis in Australia: The QUEST initiative results of a 3-month follow-up observational study
Margaret-Ann Tait, Daniel Costa, Rachel Campbell, et al.
PLoS ONE (2023) Vol. 18, Iss. 9, pp. e0290549-e0290549
Open Access | Times Cited: 11
Characterization of Cannabis usage in individuals with non-cancer chronic pain in the state of Maine using the Behavioral Risk Factor Surveillance System (BRFSS)
Rachel Bordonaro, Elizabeth N. Bean, Ling Cao
Deleted Journal (2025) Vol. 22, Iss. 1
Open Access
UK Medical Cannabis Registry: An Analysis of Clinical Outcomes of Medicinal Cannabis Therapy for Cancer Pain
Madhur Varadpande, Simon Erridge, Atul Aggarwal, et al.
Journal of Pain & Palliative Care Pharmacotherapy (2025), pp. 1-21
Open Access
Improvements in health-related quality of life are maintained long-term in patients prescribed medicinal cannabis in Australia: The QUEST Initiative 12-month follow-up observational study
Margaret-Ann Tait, Daniel Costa, Rachel Campbell, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0320756-e0320756
Open Access
Medicinal Cannabis for the Treatment of Chronic Refractory Pain: An Investigation of the Adverse Event Profile and Health-Related Quality of Life Impact of an Oral Formulation
Sarah V. Abelev, Leon N. Warne, Melissa J. Benson, et al.
Medical Cannabis and Cannabinoids (2022) Vol. 5, Iss. 1, pp. 20-31
Open Access | Times Cited: 16
Pain relief and associated factors: a cross-sectional observational web-based study in a Quebec cohort of persons living with chronic pain
Meriem Zerriouh, Gwenaëlle De Clifford‐Faugère, Hermine Lore Nguena Nguefack, et al.
Frontiers in Pain Research (2024) Vol. 5
Open Access | Times Cited: 3
Medical Cannabis and Its Efficacy/Effectiveness for the Treatment of Low-Back Pain: a Systematic Review
Cerina Lee, Elizabeth C. Danielson, Molly Beestrum, et al.
Current Pain and Headache Reports (2023) Vol. 27, Iss. 12, pp. 821-835
Closed Access | Times Cited: 7
The Quebec Cannabis Registry: Investigating the Safety and Effectiveness of Medical Cannabis
Antonio Viganò, Yola Moride, Yasmina Hachem, et al.
Cannabis and Cannabinoid Research (2022) Vol. 8, Iss. 6, pp. 1106-1116
Closed Access | Times Cited: 10
Thoughtfully Integrating Cannabis Products Into Chronic Pain Treatment
Kevin F. Boehnke, Christopher L. Wu, Daniel J. Clauw
Anesthesia & Analgesia (2023) Vol. 138, Iss. 1, pp. 5-15
Open Access | Times Cited: 6
Measuring the Change in Health-Related Quality of Life in Patients Using Marijuana for Pain Relief
Andrew M. Peterson, Christine Le, Tyler Dautrich
Medical Cannabis and Cannabinoids (2021) Vol. 4, Iss. 2, pp. 114-120
Open Access | Times Cited: 13
Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients
Prabjit Ajrawat, Yi Yang, Ewa Wasilewski, et al.
Cannabis and Cannabinoid Research (2022) Vol. 9, Iss. 1, pp. 267-281
Closed Access | Times Cited: 9
A Retrospective Medical Record Review of Adults with Non-Cancer Diagnoses Prescribed Medicinal Cannabis
Michael J. Morris, Richard Chye, Zhixin Liu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1483-1483
Open Access | Times Cited: 5
Cannabis-based medicinal products (CBMPs) for the treatment of Long COVID symptoms: current and potential applications
Hannah Thurgur, Anne Katrin Schlag, Elizabeth Iveson, et al.
Exploration of Medicine (2023), pp. 487-503
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top